Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 37Unknown 9Terminated 6Withdrawn 3Recruiting 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 14Leukemia, Biphenotypic, Acute 9Leukemia, Myeloid, Acute 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Myelodysplastic Syndromes 3Lymphoma 3Breast Neoplasms 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Primary Myelofibrosis 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Leukemia, Large Granular Lymphocytic 2Hematologic Neoplasms 2Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Polycythemia Vera 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Mouth Neoplasms 1Meningeal Neoplasms 1

Interventions

Fulvestrant 60Capecitabine 47Trastuzumab 46Letrozole 45pembrolizumab 42Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37abemaciclib 36pertuzumab 34Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Surveys and Questionnaires 26Docetaxel 26Tamoxifen 25Anastrozole 25exemestane 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Methotrexate × Clear all
NCT02422641 2026-05-26

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Wake Forest University Health Sciences

Phase 2 Recruiting
16 enrolled
Breast

Breast Neoplasms, Meningeal Neoplasms

NCT06085742 2025-12-19

BRE-08

University of Illinois at Chicago

Phase 2 Recruiting
25 enrolled
Breast

Breast Neoplasms

NCT02897700 2024-04-17

COC-IDCB

Shanghai Jiao Tong University School of Medicine

Phase 1 Recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡